Prediagnostic Circulating Sex Hormones Are Not Associated with Mortality for Men with Prostate Cancer
Open Access
- 14 January 2013
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 65 (4) , 683-689
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Serum Sex Steroids Depict a Nonlinear U-Shaped Association with High-Risk Prostate Cancer at Radical ProstatectomyClinical Cancer Research, 2012
- Physical Activity after Diagnosis and Risk of Prostate Cancer Progression: Data from the Cancer of the Prostate Strategic Urologic Research EndeavorCancer Research, 2011
- Preoperative hypogonadism is not an independent predictor of high‐risk disease in patients undergoing radical prostatectomyCancer, 2011
- Sex hormone‐binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomyBJU International, 2010
- Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysisThe Lancet Oncology, 2008
- The role of testosterone in the pathogenesis of prostate cancerInternational Journal of Urology, 2008
- Association between prostate cancer and serum testosterone levelsThe Prostate, 2002
- Pretreatment Serum Level of Testosterone as a Prognostic Factor in Japanese Men with Hormonally Treated Stage D2 Prostate Cancer.Endocrine Journal, 2001
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Peripheral and Prostatic Vein Steroid Concentrations in Benign Prostatic Hypertrophy Patients Before and After Removal of the AdenomaScandinavian Journal of Urology and Nephrology, 1980